Jean-Marc Bellemin
Director of Finance/CFO at IOVANCE BIOTHERAPEUTICS, INC.
Net worth: 868 096 $ as of 2024-03-30
Profile
Jean-Marc Bellemin holds the position of CFO & Principal Accounting Officer of Iovance Biotherapeutics, Inc. In the past he was Chief Financial Officer & Executive Vice President for Gritstone Oncology, Inc. and Senior Vice President-Business Solutions at Actelion Pharmaceuticals US, Inc. Mr. Bellemin received an undergraduate degree from Université Paris Dauphine-PSL, a graduate degree from Université Paris II Panthéon Assas and an MBA from ESSEC Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-29 | 58,576 ( 0.02% ) | 868 096 $ | 2024-03-30 |
Jean-Marc Bellemin active positions
| Companies | Position | Start |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 2020-12-13 |
Former positions of Jean-Marc Bellemin
| Companies | Position | End |
|---|---|---|
| GRITSTONE BIO, INC. | Director of Finance/CFO | 2020-12-10 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 2017-11-30 |
Training of Jean-Marc Bellemin
| Université Paris Dauphine-PSL | Undergraduate Degree |
| ESSEC Business School | Masters Business Admin |
| Université Paris II Panthéon Assas | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| GRITSTONE BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Stock Market
- Insiders
- Jean-Marc Bellemin
